Guangdong 999 Brain Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.999brain.com/en
Clinical Trials
5
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:4
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (80.0%)Not Applicable
1 (20.0%)Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
Phase 1
Completed
- Conditions
- Glioblastoma
- First Posted Date
- 2016-06-21
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Guangdong 999 Brain Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02808364
- Locations
- 🇨🇳
Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China
Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)
Phase 1
Completed
- Conditions
- Brain CancerNeoplasm Metastases
- First Posted Date
- 2016-06-21
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Guangdong 999 Brain Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02808416
- Locations
- 🇨🇳
Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China
Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
Phase 1
Completed
- Conditions
- Glioblastoma
- First Posted Date
- 2016-03-16
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Guangdong 999 Brain Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02709616
- Locations
- 🇨🇳
Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China
News
No news found